nitrates has been researched along with sorafenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexandre, J; Batteux, F; Chaussade, S; Chéreau, C; Coriat, R; Goldwasser, F; Mir, O; Nicco, C; Ropert, S; Weill, B | 1 |
1 trial(s) available for nitrates and sorafenib
Article | Year |
---|---|
Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo.
Topics: Advanced Oxidation Protein Products; Aged; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Niacinamide; Nitrates; Phenylurea Compounds; Reactive Oxygen Species; Sorafenib | 2012 |